Skip to main content
. Author manuscript; available in PMC: 2016 Feb 10.
Published in final edited form as: Anticancer Drugs. 2016 Mar;27(3):216–224. doi: 10.1097/CAD.0000000000000319

Figure 4. VRL on angiogenic markers.

Figure 4

Angiogenic (A) and anti-angiogenic (B) markers after applying the metronomic (left) or the conventional (right) chemotherapy in vitro model.*p<0.05 compared with control group.